Irritable Bowel Syndrome (IBS) Market Report

Global and Region Irritable Bowel Syndrome (IBS) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：137
  • REPORT CODE：GMM939795
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Irritable Bowel Syndrome (IBS) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Irritable Bowel Syndrome (IBS)market, defines the market attractiveness level of Irritable Bowel Syndrome (IBS) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Irritable Bowel Syndrome (IBS) industry, describes the types of Irritable Bowel Syndrome (IBS) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Irritable Bowel Syndrome (IBS) market and the development prospects and opportunities of Irritable Bowel Syndrome (IBS) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Irritable Bowel Syndrome (IBS) market in Chapter 13.

    By Player:

    • Takeda

    • Allergan

    • Astellas Pharmaceuticals

    • Sebela Pharmaceuticals

    • McNeil Consumer Healthcare

    • Sucampo Pharmaceuticals

    • IM HealthScience

    • Valeant Pharmaceuticals

    By Type:

    • IBS-D Drug

    • IBS-C Drug

    • Other

    By End-User:

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Irritable Bowel Syndrome (IBS) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Irritable Bowel Syndrome (IBS) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Irritable Bowel Syndrome (IBS) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Irritable Bowel Syndrome (IBS) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Irritable Bowel Syndrome (IBS) Market Analysis and Outlook to 2022

    • 7.1 Global Irritable Bowel Syndrome (IBS) Consumption (2017-2022)

    • 7.2 United States Irritable Bowel Syndrome (IBS) Consumption (2017-2022)

    • 7.3 Europe Irritable Bowel Syndrome (IBS) Consumption (2017-2022)

    • 7.4 China Irritable Bowel Syndrome (IBS) Consumption (2017-2022)

    • 7.5 Japan Irritable Bowel Syndrome (IBS) Consumption (2017-2022)

    • 7.6 India Irritable Bowel Syndrome (IBS) Consumption (2017-2022)

    • 7.7 South Korea Irritable Bowel Syndrome (IBS) Consumption (2017-2022)

    8 Region and Country-wise Irritable Bowel Syndrome (IBS) Market Analysis and Outlook to 2028

    • 8.1 Global Irritable Bowel Syndrome (IBS) Consumption Forecast (2022-2028)

    • 8.2 United States Irritable Bowel Syndrome (IBS) Consumption Forecast (2022-2028)

    • 8.3 Europe Irritable Bowel Syndrome (IBS) Consumption Forecast (2022-2028)

    • 8.4 China Irritable Bowel Syndrome (IBS) Consumption Forecast (2022-2028)

    • 8.5 Japan Irritable Bowel Syndrome (IBS) Consumption Forecast (2022-2028)

    • 8.6 India Irritable Bowel Syndrome (IBS) Consumption Forecast (2022-2028)

    • 8.7 South Korea Irritable Bowel Syndrome (IBS) Consumption Forecast (2022-2028)

    9 Global Irritable Bowel Syndrome (IBS) Market Outlook by Types and Applications to 2022

    • 9.1 Global Irritable Bowel Syndrome (IBS) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global IBS-D Drug Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global IBS-C Drug Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Irritable Bowel Syndrome (IBS) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Irritable Bowel Syndrome (IBS) Market Outlook by Types and Applications to 2028

    • 10.1 Global Irritable Bowel Syndrome (IBS) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global IBS-D Drug Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global IBS-C Drug Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Irritable Bowel Syndrome (IBS) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Irritable Bowel Syndrome (IBS) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Irritable Bowel Syndrome (IBS) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Irritable Bowel Syndrome (IBS) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Irritable Bowel Syndrome (IBS) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Irritable Bowel Syndrome (IBS) Market Competitive Analysis

    • 14.1 Takeda

      • 14.1.1 Takeda Company Details

      • 14.1.2 Takeda Irritable Bowel Syndrome (IBS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Takeda Irritable Bowel Syndrome (IBS) Product and Service

    • 14.2 Allergan

      • 14.2.1 Allergan Company Details

      • 14.2.2 Allergan Irritable Bowel Syndrome (IBS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Allergan Irritable Bowel Syndrome (IBS) Product and Service

    • 14.3 Astellas Pharmaceuticals

      • 14.3.1 Astellas Pharmaceuticals Company Details

      • 14.3.2 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product and Service

    • 14.4 Sebela Pharmaceuticals

      • 14.4.1 Sebela Pharmaceuticals Company Details

      • 14.4.2 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Product and Service

    • 14.5 McNeil Consumer Healthcare

      • 14.5.1 McNeil Consumer Healthcare Company Details

      • 14.5.2 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Product and Service

    • 14.6 Sucampo Pharmaceuticals

      • 14.6.1 Sucampo Pharmaceuticals Company Details

      • 14.6.2 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Product and Service

    • 14.7 IM HealthScience

      • 14.7.1 IM HealthScience Company Details

      • 14.7.2 IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 IM HealthScience Irritable Bowel Syndrome (IBS) Product and Service

    • 14.8 Valeant Pharmaceuticals

      • 14.8.1 Valeant Pharmaceuticals Company Details

      • 14.8.2 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Irritable Bowel Syndrome (IBS)

    • Figure Irritable Bowel Syndrome (IBS) Picture

    • Table Global Irritable Bowel Syndrome (IBS) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Irritable Bowel Syndrome (IBS) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Irritable Bowel Syndrome (IBS) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Irritable Bowel Syndrome (IBS) Consumption by Country (2017-2022)

    • Figure United States Irritable Bowel Syndrome (IBS) Consumption and Growth Rate (2017-2022)

    • Table Europe Irritable Bowel Syndrome (IBS) Consumption and Growth Rate (2017-2022)

    • Figure China Irritable Bowel Syndrome (IBS) Consumption and Growth Rate (2017-2022)

    • Figure Japan Irritable Bowel Syndrome (IBS) Consumption and Growth Rate (2017-2022)

    • Figure India Irritable Bowel Syndrome (IBS) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Irritable Bowel Syndrome (IBS) Consumption and Growth Rate (2017-2022)

    • Figure Global Irritable Bowel Syndrome (IBS) Consumption Forecast by Country (2022-2028)

    • Figure United States Irritable Bowel Syndrome (IBS) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Irritable Bowel Syndrome (IBS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Irritable Bowel Syndrome (IBS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Irritable Bowel Syndrome (IBS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Irritable Bowel Syndrome (IBS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global IBS-D Drug Consumption and Growth Rate (2017-2022)

    • Figure Global IBS-C Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global IBS-D Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global IBS-C Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Irritable Bowel Syndrome (IBS) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Irritable Bowel Syndrome (IBS) Export by Region (Top 5 Countries) (2017-2028)

    • Table Takeda (Foundation Year, Company Profile and etc.)

    • Table Takeda Irritable Bowel Syndrome (IBS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Irritable Bowel Syndrome (IBS) Product and Service

    • Table Allergan (Foundation Year, Company Profile and etc.)

    • Table Allergan Irritable Bowel Syndrome (IBS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Irritable Bowel Syndrome (IBS) Product and Service

    • Table Astellas Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product and Service

    • Table Sebela Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Product and Service

    • Table McNeil Consumer Healthcare (Foundation Year, Company Profile and etc.)

    • Table McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Product and Service

    • Table Sucampo Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Product and Service

    • Table IM HealthScience (Foundation Year, Company Profile and etc.)

    • Table IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table IM HealthScience Irritable Bowel Syndrome (IBS) Product and Service

    • Table Valeant Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US